This article is organized as follows
Gut-Brain Axis GLP-1 Anti-Obesity Rx and Alcohol and Substance Use Disorders GLP-1 medications targeting the brain or gut may improve treatment of addictions
Retatrutide is an investigational peptide-based medicine currently under clinical evaluation for the treatment of obesity and type 2 diabetes mellitus
By improving muscle mass, people may also reduce the appearance of sagging skin associated with weight loss
The physical properties of this compound include a density of 0.925 g/mL at 20C, with different sources reporting varying physical states ranging from liquid to low melting-point solid (-5 to -4C), likely due to different isomeric compositions or purity levels [1] [2]
For example, lower body negative pressure (LBNP) is used to draw blood back into the lower limb veins and has shown beneficial effects on ICP [98], intraocular pressure [99], optic nerve sheath diameter [100] and internal jugular vein volume [101]